CLEARPOINT NEURO INC's ticker is CLPT and the CUSIP is 18507C103. A total of 64 filers reported holding CLEARPOINT NEURO INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,143 | -30.8% | 6,216 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $45,004 | -14.2% | 6,216 | 0.0% | 0.01% | -18.2% |
| Q1 2023 | $52,464 | -0.4% | 6,216 | 0.0% | 0.01% | -8.3% |
| Q4 2022 | $52,650 | -17.7% | 6,216 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $64,000 | -21.0% | 6,216 | 0.0% | 0.02% | -18.2% |
| Q2 2022 | $81,000 | +376.5% | 6,216 | +271.1% | 0.02% | +175.0% |
| Q1 2022 | $17,000 | -32.0% | 1,675 | -24.4% | 0.01% | +14.3% |
| Q4 2021 | $25,000 | -35.9% | 2,216 | 0.0% | 0.01% | -46.2% |
| Q3 2021 | $39,000 | -53.6% | 2,216 | -49.4% | 0.01% | -58.1% |
| Q2 2021 | $84,000 | -9.7% | 4,377 | 0.0% | 0.03% | -22.5% |
| Q1 2021 | $93,000 | +32.9% | 4,377 | 0.0% | 0.04% | +25.0% |
| Q4 2020 | $70,000 | +191.7% | 4,377 | 0.0% | 0.03% | +166.7% |
| Q3 2020 | $24,000 | +200.0% | 4,377 | +97.5% | 0.01% | +200.0% |
| Q2 2020 | $8,000 | 0.0% | 2,216 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $8,000 | – | 2,216 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parian Global Management LP | 678,999 | $12,962,000 | 5.56% |
| Taylor Frigon Capital Management LLC | 175,690 | $3,354,000 | 1.05% |
| Mayo Clinic | 38,114 | $728,000 | 0.80% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $764,000 | 0.66% |
| Blackcrane Capital, LLC | 27,653 | $528,000 | 0.64% |
| Parian Global Management LP | 75,000 | $1,432,000 | 0.62% |
| Triumph Capital Management | 29,509 | $500,000 | 0.29% |
| AlphaCentric Advisors LLC | 50,000 | $955,000 | 0.26% |
| KIRR MARBACH & CO LLC /IN/ | 45,200 | $863,000 | 0.24% |
| Kepos Capital LP | 125,000 | $2,386,000 | 0.18% |